Luboń et al., 1996 - Google Patents
Blood proteins from transgenic animal bioreactorsLuboń et al., 1996
- Document ID
- 6686334821157565135
- Author
- Luboń H
- Paleyanda R
- Velander W
- Drohan W
- Publication year
- Publication venue
- Transfusion Medicine Reviews
External Links
Snippet
Fig 1. Engineering the mammary gland of a transgenic animal bioreactor. Human plasma proteins are targeted for expression to specific organs like the mammary gland of transgenic animal bioreactors (TABs), using hybrid genes containing the tissue-specific regulatory …
- 102000004506 Blood Proteins 0 title description 10
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6437—Coagulation factor VIIa (3.4.21.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Luboń et al. | Blood proteins from transgenic animal bioreactors | |
| EP0971724B1 (en) | Expression of active human factor ix in mammary tissue of transgenic animals | |
| KR101312390B1 (en) | Recombinant or transgenic factor ⅶ composition, each factor ⅶ molecule having two n-glycosylation sites with defined glycan units | |
| US7888321B2 (en) | Production of high levels of transgenic factor IX without gene rescue, and its therapeutic uses | |
| Niemann et al. | Expression of human blood clotting factor VIII in the mammary gland of transgenic sheep | |
| Echelard | Recombinant protein production in transgenic animals | |
| Bawden et al. | The genes encoding the major milk-specific proteins and their use in transgenic studies and protein engineering | |
| Meade et al. | Expression of recombinant proteins in the milk of transgenic animals | |
| US20070011752A1 (en) | Production of human proteins in transgenic animal saliva | |
| Bösze et al. | Producing recombinant human milk proteins in the milk of livestock species | |
| WO1997020043A1 (en) | Protein c production in transgenic animals | |
| WO2002077161A2 (en) | Production of high levels of trangenic factor ix without gene rescue, and its therapeutic uses | |
| US20020073438A1 (en) | Methods of purifying human acid alpha-glucosidase | |
| Lisauskas et al. | Expression of functional recombinant human factor IX in milk of mice | |
| US20040161837A1 (en) | Methods of purifying human acid alpha-glucosidase | |
| EP0874898B1 (en) | Protein c production in transgenic animals | |
| Drohan | The past, present and future of transgenic bioreactors | |
| Xu | Production of recombinant human coagulation factor IX by transgenic pig | |
| Drohan et al. | Progress in transgenic production of human plasma proteins in mammary bioreactors | |
| Velander | Expression of active human factor IX in mammary tissue and of milk non human transgenic mammals | |
| Ayares | Transgenic protein production: Achievements using microinjection technology and the promise of nuclear transfer | |
| AU2002305043A1 (en) | Production of high levels of trangenic factor IX without gene rescue, and its therapeutic uses | |
| Van Cott | Upstream and downstream issues in the production of recombinant vitamin K-dependent proteins in the milk of transgenic pigs | |
| Velander et al. | Protein Expression Using Transgenic Animals | |
| AU2002254193A1 (en) | Production of high levels of transgenic factor VIII with engineered stability, and its therapeutic uses |